Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Apr 14, 2024; 30(14): 1990-2005
Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.1990
Table 1 Clinical characteristics of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
Gender0.013
Male61 (63.5)a76 (76.0)a,b73 (82.0)b9 (56.3)a,b
Female35 (36.5)a24 (24.0)a,b16 (18.0)b7 (43.8)a,b
Age (yr) (range)57 (55-59)a63 (61-65)b63 (61-65)b64 (59-68)a,b< 0.001
Comorbidity
Diabetes6 (6.3)15 (15.0)9 (10.1)0 (0.0)0.108
Hypertension17 (17.7)31 (31.0)19 (21.3)4 (25.0)0.161
Cardiovascular disease5 (5.2)8 (8.0)9 (10.1)2 (12.5)0.572
Liver cirrhosis5 (5.2)1 (1.0)2 (2.2)0 (0.0)0.265
Chronic pulmonary disease2 (2.1)6 (6.0)1 (1.1)0 (0.0)0.175
Reflux esophagitis15 (15.6)12 (12.0) 11 (12.4) 3 (18.8)0.794
Barrett’s esophagus4 (4.2)2 (2.0) 1 (1.1) 0 (0.0)0.489
Atrophic gastritis72 (75.0)a93 (93.0)b84 (94.4)b13 (81.3)a,b< 0.001
Previous gastric cancer1 (1.0)0 (0.0)2 (2.2)0 (0.0)0.461
Smoking history 26 (27.1)a49 (49.0)b45 (50.6)b6 (37.5)a,b0.004
Drinking history24 (25.0)31 (31.0)24 (27.0)3 (18.8)0.673
Family history15 (15.6)11 (11.0)19 (21.3)0 (0.0)0.074
Table 2 Pathological characteristics of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
Size (cm) (range)2.7 (2.2-3.7)a3.2 (2.4-3.7)a,b3.7 (2.7-4.2)b3.5 (2.8-4.6)b0.001
Location0.006
Top 1/319 (19.8)30 (30.0)33 (37.1)2 (12.5)
Medium 1/310 (10.4)22 (22.0)13 (14.6)5 (31.3)
Lower 1/367 (69.8)a48 (48.0)b43 (48.3)b9 (56.3)a,b
Paris classification< 0.001
0-I24 (25.0)a3 (3.0)b3 (3.4)b2 (12.5)a,b
0-IIa19 (19.8)14 (14.0)11 (12.4)0 (0.0)
0-IIb9 (9.4)11 (11.0)9 (10.1)0 (0.0)
0-IIc20 (20.8)a39 (39.0)b39 (43.8)b8 (50.0)a,b
0-III1 (1.0)1 (1.0)1 (1.1)0 (0.0)
0-IIa+ IIc23 (24.0)32 (32.0)26 (29.2)6 (37.5)
Invasion depth< 0.001
M1M296 (100.0)a100 (100.0)a43 (48.3)b5 (31.3)b
M30 (0.0)a0 (0.0)a37 (41.6)b6 (37.5)b
SM10 (0.0)a,b0 (0.0)b6 (6.7)a,c2 (12.5)c
SM20 (0.0)a0 (0.0)a3 (3.4)a,b3 (18.8)b
Presence of H. pylori37 (48.7)38 (52.8)32 (56.1)4 (40.0)0.727
Presence of ulceration6 (6.3)6 (6.0)7 (7.9)4 (25.0)0.058
Table 3 The white light endoscopic manifestations of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
Nodularity65 (67.7)65 (65.0)60 (67.4)11 (68.8)0.974
Redness51 (53.1)50 (50.0)60 (67.4)7 (43.8)0.059
Whiteness7 (7.3)5 (5.0)2 (2.2)0 (0.0)0.324
White moss10 (10.4)14 (14.0)15 (16.9)2 (12.5)0.646
Spontaneous bleeding 3 (3.1)a11 (11.0)a,b18 (20.2)b0 (0.0)a,b0.001
Abnormal fold 3 (3.1)a1 (1.0)a6 (6.7)a,b4 (25.0)b< 0.001
Poor peristalsis 2 (2.1)a,b1 (1.0)b9 (10.1)a,c3 (18.8)c< 0.001
Table 4 Magnified endoscopy with narrow-band imaging manifestations of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
IMVP25 (38.5)a51 (66.2)b49 (77.8)b11 (100.0)b< 0.001
IMSP32 (49.2)a46 (59.7)a,b44 (69.8)a,b10 (90.9)b0.018
DL46 (63.0)a69 (86.3)b58 (90.6)b11 (91.7)b< 0.001
Table 5 Endoscopic submucosal dissection efficacy and safety of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
Absolute indication91 (94.8)a,b97 (97.0)b77 (86.5)a2 (12.5)c< 0.001
En bloc resection93 (96.9)98 (98.0)88 (98.9)16 (100.0)0.729
Complete resection 88 (91.7)90 (90.0)79 (88.8)13 (81.3)0.630
Curative resection83 (86.5)a87 (87.0)a70 (78.7)a2 (12.5)b< 0.001
Complication 5 (5.2)a5 (5.0)a3 (3.4)a4 (25.0)b0.007
Bleeding 3 (3.1)a,b1 (1.0)b2 (2.2)b3 (18.8)a0.002
Perforation 2 (2.1)4 (4.0)2 (2.2)1 (6.3)0.710
Stenosis 0 (0.0)a0 (0.0)a0 (0.0)a1 (6.3)b< 0.001
Table 6 Follow-up results of gastric mucosal tumors with different degrees of differentiation, n (%)

LGIN (n = 96)
HGIN (n = 100)
Differentiated-type (n = 89)
Undifferentiated-type (n = 16)
P value
BMI (range)23.87 (23.19-24.54)a23.09 (22.41-23.77)a,b22.37 (21.71-23.02)b21.44 (20.08-22.79)b0.003
Adverse outcome 8 (8.3)a6 (6.0)a7 (7.9)a6 (37.5)b< 0.001
Recurrence 5 (5.2)6 (6.0)6 (6.7)2 (12.5)0.734
Metastasis 3 (3.1)a,b0 (0.0)b2 (2.2)b3 (18.8)a< 0.001
Multiple primary cancer 24 (25.0)15 (15.0)15 (16.9)4 (25.0)0.276
Table 7 Multivariate analysis of time-related factors of adverse outcomes such as recurrence, metastasis and death
Variable
Category
P value
Hazard ratio
95%CI
Differentiation degreeUndifferentiated-type0.0045.0661.688-15.200
LGIN1
White mossYes< 0.0017.1873.122-16.546
No1
Complete resectionNo0.0123.6581.337-10.010
Yes1
Multiple primary cancerYes0.0302.4621.090-5.562
No1
Table 8 Multivariate analysis of factors associated with incomplete resection
Variable
Category
P value
Odds ratio
95%CI
Invasion depthM1M20.00411.2002.120-59.163
M30.0327.6001.192-48.437
SM2-1-
Table 9 Multivariate analysis of factors associated with noncurative resection
Variable
Category
P value
Odds ratio
95%CI
Peristaltic conditionPoor0.0090.1850.052-0.653
Normal1
Microsurface patternIrregular0.0430.4100.173-0.972
Regular1
UlcerationYes< 0.0010.0730.026-0.207
No1
Table 10 Multivariate analysis of complications related factors
Variable
Categor
P value
Odds ratio
95%CI
Histologic typeSignet ring cell (sig)0.03232.6271.357-784.415
Mucinous (muc)0.00649.8553.051-814.724
LGIN-1-
Paris classification0-III0.02030.4061.695-545.565
0-I1
Table 11 Multivariate analysis of factors related to postoperative pathological degradation
Variable
Category
P value
Odds ratio
95%CI
LocationLower 1/30.0372.3991.055-5.455
Top 1/31
Barrett’s esophagusYes0.0267.8051.277-47.689
No1
Table 12 Multivariate analysis of factors related to postoperative pathological upgrading
Variable
P value
Odds ratio
95%CI
BMI0.0220.9060.833-0.986